Readers Respond: Sarbanes-Oxley: In Search of Payback | eWeek

Readers Respond: Sarbanes-Oxley: In Search of Payback

Written By
eWEEK EDITORS
eWEEK EDITORS
Aug 10, 2005
1 minute read
eWeek content and product recommendations are editorially independent. We may make money when you click on links to our partners. Learn More

The Sarbanes-Oxley Act was not intended to provide benefits to corporate bottom lines, but to provide benefits to stockholders and other users of financial reports (“Sarbanes-Oxley: In Search of Payback,” Aug. 8).

SarbOx was created to limit the damage caused by the Public Securities Litigation Reform Act of 1995 which (as believed by many experts) set the stage for Enron-type reporting fraud.

While that law benefited corporate bottom lines immensely, the cost to investors was in the billions of dollars. If SarbOx prevents such fraud and losses in the future, then the benefits intended will have been achieved and any benefit to corporations will be greatly appreciated icing on the cake.

James Lewis
Wilmington, Del.

Check out eWEEK.coms for the latest news, commentary and analysis on regulatory compliance.

eWeek Logo

eWeek has the latest technology news and analysis, buying guides, and product reviews for IT professionals and technology buyers. The site's focus is on innovative solutions and covering in-depth technical content. eWeek stays on the cutting edge of technology news and IT trends through interviews and expert analysis. Gain insight from top innovators and thought leaders in the fields of IT, business, enterprise software, startups, and more.

Property of TechnologyAdvice. © 2026 TechnologyAdvice. All Rights Reserved

Advertiser Disclosure: Some of the products that appear on this site are from companies from which TechnologyAdvice receives compensation. This compensation may impact how and where products appear on this site including, for example, the order in which they appear. TechnologyAdvice does not include all companies or all types of products available in the marketplace.